Serum Hepcidin Level as an Early Marker of Hematopoietic Activity after Allogeneic Peripheral Blood Stem Cell Transplantation.
- Author:
Jimyung KIM
1
;
Kye Chul KWON
;
Sun Hoe KOO
Author Information
1. Department of Laboratory Medicine, Chungnam National University School of Medicine, Daejeon, Korea. jmkim@cnuh.co.kr
- Publication Type:Original Article
- Keywords:
Hepcidin;
Peripheral blood;
Stem cell transplantation;
Hematopoiesis;
Reticulocyte count
- MeSH:
Anemia, Refractory;
Animals;
Antimicrobial Cationic Peptides;
C-Reactive Protein;
Cell Transplantation;
Ferritins;
Hematologic Neoplasms;
Hematopoiesis;
Humans;
Incidence;
Inflammation;
Iron;
Organothiophosphorus Compounds;
Peripheral Blood Stem Cell Transplantation;
Reticulocyte Count;
Stem Cell Transplantation;
Transplants
- From:Journal of Laboratory Medicine and Quality Assurance
2013;35(1):1-7
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Hepcidin plays a central role in the regulation of iron metabolism, and hepatic iron production is stimulated by iron load and inflammation. Recent animal studies have shown that hepcidin levels increase when hematopoiesis is blocked. We aimed to monitor pre- and post-stem cell transplantation hepcidin levels and evaluate its association with hematologic recovery. METHODS: The study group comprised 12 patients with hematologic malignancies (7 with AML, 4 with ALL, and 1 with refractory anemia with excess blasts-2) undergoing allogeneic peripheral blood stem cell transplantation (PBSCT). One day before and 3 days, 1 week, 2 weeks, 4 weeks, and 8 weeks after PBSCT, reticulocyte count and levels of Hb, ferritin, and C-reactive protein were monitored; serum hepcidin-25 was measured by ELISA. RESULTS: The median serum hepcidin-25 levels (ng/mL) were significantly higher until 1 week after PBSCT (103.6, 103.3, and 96.5) than those at 2, 4, and 8 weeks after PBSCT (63.9, 53.9, and 56.6, respectively). The reticulocyte count also significantly increased from 2 weeks after PBSCT. The hepcidin level showed an inverse correlation with reticulocyte count (r=-0.56, P<0.001) and a weak positive correlation with ferritin (r=0.27, P=0.02). At 2 weeks, patients with high hepcidin levels (> or =63.9) tended to demonstrate lower Hb recovery at 8 weeks than patients with low hepcidin levels did (P=0.15), but without any differences in the incidence of complications. CONCLUSIONS: These findings indicate that hepcidin production is associated with erythropoietic activity and that hepcidin level may be used as an early marker of hematopoietic recovery in PBSCT.
